Implementation of new imported immunoglobulin supply arrangements
In December 2020, the National Blood Authority (NBA) finalised a procurement process for new national contracts for the supply of imported immunoglobulin (Ig)…
19 May 2022
Transition of Australia's domestic plasma products
19 May 2022
National supply arrangements for Hemlibra (emicizumab)
On 2 November 2020, Hemlibra became available under national supply arrangements.
02 Nov 2020
Schedule 4 assessment of alpha1-proteinase inhibitor (A1-PI)
In July and September 2017, the NBA received National Blood Supply Change Proposals for purified human alpha1-proteinase inhibitor (A1-PI) for the treatment of…
14 Mar 2019